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Abstract. Degradation of type I collagen, the most 
abundant collagen, is initiated by collagenase cleavage 
at a highly conserved site between Gly775 and I1e776 of 
the od(I) chain. Mutations at or around this site render 
type I collagen resistant to collagenase digestion in 
vitro. We show here that mice carrying a collagenase- 
resistant mutant Colla-1 transgene die late in embryo- 
genesis, ascribable to overexpression of the transgene, 
since the same mutation introduced into the endoge- 
nous Colla-1 gene by gene targeting permitted normal 
development of mutant mice to young adulthood. With 
increasing age, animals carrying the targeted mutation 
developed marked fibrosis of the dermis similar to that 
in human scleroderma. Postpartum involution of the 
uterus in the mutant mice was also impaired, with per- 
sistence of collagenous nodules in the uterine wall. AI- 
though type I collagen from the homozygous mutant 
mice was resistant to cleavage by human or rat fibro- 
blast collagenases at the helical site, only the rat colla- 
genase cleaved collagen trimers at an additional, novel 
site in the nonhelical N-telopeptide domain. Our results 
suggest that cleavage by murine collagenase at the 
N-telopeptide site could account for resorption of type 
I collagen during embryonic and early adult life. During 
intense collagen resorption, however, such as in the im- 
mediate postpartum uterus and in the dermis later in 
life, cleavage at the helical site is essential for normal 
collagen turnover. Thus, type I collagen is degraded by 
at least two differentially controlled mechanisms in- 
volving collagenases with distinct, but overlapping, 
substrate specificities. 
T 
YPE I collagen is among the most abundant compo- 
nents  of the  extracellular  matrix  of many tissues, 
particularly in skin, tendons, ligaments, uterus, large 
blood vessels and bone. The helical  trimeric molecules of 
type I  collagen comprise two al(I) chains  and one ~2(I) 
chain,  encoded  by  two  separate  genes,  Colla-1  and 
Colla-2, respectively (50). In mice, type I collagen is first 
synthesized in the mesenchymal stroma of the head, heart 
and somites at day 8 of gestation (E8) and its production 
continues throughout development and postnatal life (27). 
It has been demonstrated that type I collagen is critical for 
bone development (9, 10), hematopoiesis (29, 37), integ- 
rity of the vascular system (29) and for mesenchymal-epi- 
thelial induction in organogenesis (6). 
The collagen content of different tissues during develop- 
ment and in adult animals  is tightly regulated by coordi- 
nated processes of synthesis and  degradation  (2, 8,  57). 
Failure to maintain an equilibrium between synthesis and 
degradation leads to diverse human connective tissue dis- 
orders  characterized  by  excessive  resorption  (e.g.  os- 
m 
Address all correspondence to R. Jaenisch, The Whitehead Institute for 
Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142. 
Ph.: (617) 258-5186. Fax: (617) 258-6505. 
teoporosis  or  inflammatory  joint  diseases)  or  excessive 
deposition  (e.g.  pulmonary fibrosis or scleroderma)  (32, 
39). The degradation of type I collagen requires the action 
of specific collagenases since native,  triple-helical  mole- 
cules are resistant to attack by proteolytic enzymes at 37°C 
and neutral pH. The collagenases are members of a family 
of proteinases, the metalloproteinases or matrixins,  all of 
which  contain  a  catalytic  zinc-binding  domain  that  in- 
cludes the  sequence motif HEXXH where the  Glu  (E) 
acts as a catalytic base. The peptide bonds between resi- 
dues Gly775 and  Ile776 of the ~1(I)  chain  and  Gly775 and 
Leu776 of the et2(I) chain are the only sites in native type I 
collagen molecules known to be cleaved by collagenases 
from various species including  enzymes isolated from hu- 
man, bovine, pig and rabbit. These cleavage sites are con- 
served in collagens from amphibians to mammals and are 
similar in types I, II, and III collagens (8). Cleavage of the 
collagens at this specific site leads to the production of a 
three-quarter  length  helical fragment  (TC  a)  and  a  one- 
quarter length helical fragment (TC  B) (51). The activity of 
collagenases released from cells is under the regulation of 
proteolytic collagenase  activators  and  specific inhibitors 
known as TIMPs (tissue inhibitors of metalloproteinases) 
(34, 35). 
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play  an  important  role  in  development  of  collagenous 
structures by altering morphogenetic tissue interactions (6, 
8). The evidence supporting this role is largely circumstan- 
tial and is based on the specific expression patterns of met- 
aUoproteinases or specific inhibitory proteins during par- 
ticular stages  of development (8).  Recently, it has  been 
possible  to  obtain  more  direct  evidence for the  role  of 
metalloproteinases in transgenic mice which overexpress 
stromelysin-1, a proteinase which degrades components of 
basement membranes. Expression of the transgene was as- 
sociated with altered branching patterns of the mammary 
ducts and aberrant expression of 13-casein as well as whey 
acidic protein (48). 
We have used a  genetic approach to obtain direct evi- 
dence for the role of type I collagen degradation in devel- 
opment and disease. Our strategy has involved the genera- 
tion of a mutant substrate resistant to enzyme cleavage. In 
previous experiments, we introduced five different muta- 
tions into the collagenase cleavage domain of the Colla-1 
gene and demonstrated that substitution of a Pro for Ile776 
or the stabilization of the helix by substitutions of Pro for 
Gln774 and Ala777 at P2 and P2'  rendered native collagen 
produced by cells in culture resistant to collagenase diges- 
tion (58). 
In the present study, we introduced one of the mutations 
(mutation IV with a stabilized triple helix) into the mouse 
genome using two different approaches. Transgenic mice 
carrying multiple copies of the mutant transgene died dur- 
ing gestation. In contrast, mice carrying the mutation in 
the endogenous Colla-1 gene developed normally and dis- 
played no obvious abnormalities as young adults. Begin- 
ning at approximately seven months of age, mutant mice 
began to develop thickened skin and patchy hair loss due 
to dermal fibrosis. In  addition, postpartum involution of 
the uterus in mutant females was impaired. While the mu- 
tant collagen was completely resistant to cleavage at the 
known cleavage site by the human and rat enzymes, rat fi- 
broblast  collagenase  recognized  an  additional  cleavage 
site COOH-terminal to the N-telopeptide crosslink.  Our 
results  suggest  that  the  ability  of rodent  collagenase  to 
cleave at this additional NH2-terminal locus permits nor- 
mal remodeling during development and  early postnatal 
life, but that cleavage at the helical site is required for sub- 
sequent remodeling of the extracellular matrices in tissues 
such as those in skin and the postpartum uterus in which 
type I collagen is particularly abundant. 
Materials and Methods 
Materials 
Pepsin, (2,858  U/mg; Cooper Biomedical), trypsin, TPCK, and soybean 
trypsin inhibitor were purchased from Worthington Biochemical Corpo- 
ration ( Freehold, NJ ). 
p-Aminophenylmercuric acetate (APMA)  1 was purchased from Sigma 
Chemical Company (St. Louis, MO). 
Generation of Transgenics 
Transgenics were derived as described previously (59).  A  linearized ge- 
1.  Abbreviatwns  used  m  this paper:.  APMA, p-aminophenylmercuric ace- 
tate; ES, embryonic stem. 
nomic DNA fragment that included about 17 kb of coding region and 3.7 
kb of 5'and 3 kb of 3' flanking sequences of the Colla-1 gene carrying mu- 
tation IV  (58)  was microinjected into the pronucleus of fertilized FVB 
eggs. The eggs were incubated overnight and two-cell embryos were trans- 
ferred to the oviduct of pseudopregnant females. 
Generation of Chimeras and Germlines 
J1 ES cells carrying the subtle mutations (mutation IV) at the collagenase 
cleavage site (60) were injected into C57-BL/6 and BALB/c embryos as 
described (28).  Chimeras were identified on the basis of agouti pigmenta- 
tion in the coat. C57BL/6 and BALB/c chimeras were backcrossed and 
their agouti offspring were genotyped by Southern blot analysis. 
Southern Blot Analysis 
Embryo and tad DNAs were prepared according to Laird et al. (26).  The 
DNA was digested with Sph I and electrophoresed in a 0.7% agarose gel. 
The DNA was denatured, neutralized and transferred onto Hybond nylon 
membranes (Amersham Corp.,  Arlington Heights, IL)  as described  by 
Sambrook et al. (43). The probe is shown in Fig. 2. 
Preparation of Collagens and Digestion 
with Collagenases 
Collagens were extracted from mouse skin, tail, or whole embryos by di- 
gestion with pepsin, 50 I~g/ml, in 0.5 M  acetic acid at 0-4°C for 2-4 d. In 
some samples, extraction was carried out under the same conditions, but 
without pepsin. The insoluble residue was removed by centrifugation and 
the collagen content of an aliquot portion was determined by measure- 
ment of hydroxyproline content following acid hydrolysis (5). The pepsin 
was inactivated by neutralization with NaOH and the solution was dia- 
lyzed against Cl: collagenase buffer (0.15  M  NaCI, 0.05 M Tris-HCl, pH 
7.4, 10 mM CAC12/0.25 M  glucose) overnight at 4°C (58). Incubation with 
collagenase was usually for 18-20 h at 20°C and the reaction was stopped 
by the addition of EDTA to a final concentration of 50 raM; the samples 
were stored at 4°C prior to analysis by SDS-PAGE (15). Digestion prod- 
ucts  were  resolved  by  SDS-PAGE  using 5  or  7%  acrylamide without 
reduction and gels were stained with Coomassie blue. The human colla- 
genase preparation used here was partially purified from medium condi- 
tioned by cultured rheumatoid synovial fibroblasts as previously described 
(12).  Rat collagenase was purified from medium conditioned by postpar- 
tum rat uterine cells as previously described (42).  The latent collagenase 
was activated with trypsin, 5 ~g/ml for 10 min at 20°C and the trypsin inac- 
tivated with excess soybean trypsin inhibitor (12); alternatively, activation 
was with APMA. 1 mM, added at the beginning of the incubation (7, 36). 
For quantitation of relative protein content of appropriate stained bands 
after SDS-PAGE,  photographs of stained gels were  analyzed using the 
Hewlett  Packard  (Santa  Clara,  CA)  H-P  DeskScanII  scanner and  the 
Scan  Analysis program  (Biosoft,  Cambridge,  UK)  for  the  Macintosh 
computer. Cyanogen bromide  digestion of collagens was performed  as 
previously described (58) in order to determine the incorporation of the 
mutated al(I)  chain. Band 7a (58)  was quantltated, after resolution by 
SDS-PAGE, by densitometry. 
NH2-terminal Peptide Sequencing 
Collagen from the  skin of mice homozygous for  mutation IV  was ex- 
tracted as described, in 0.5 M acetic acid without pepsin. One sample was 
incubated in collagenase buffer with purified rat fibroblast collagenase for 
18 h  at 20°C;  the other sample was incubated in buffer alone. Approxi- 
mately 150  txg of each was loaded  into  individual wells of a  5%  poly- 
acrylamide gel for  SDS-PAGE.  Proteins were  stained with  Coomassie 
blue  and  blotted  onto  Immobilon-P  (polyvinyl  fluoride)  membranes 
(Millipore  Corporation,  Bedford,  MA).  The proteins corresponding to 
"al(I)" chains were cut out and peptide sequencing was performed as de- 
scribed (30). 
Histological Analysis 
Uterus and skin from age and sex matched wild-type and homozygous 
mutant mice were  dissected and fLxed in  10%  buffered Formalin. They 
were then placed in successive ethanol and xylene baths and finally em- 
bedded in Paraplast Plus (Oxford, UK) using an Autotechnicon embed- 
der (Technicon). The embedded tissues were sectioned to 5 Ixm using a 
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scribed (3). 
Results 
Mice Carrying a Colla-1 Transgene with 
Mutations at the Collagenase Cleavage Site Die 
During Late Gestation 
To address the role of collagenases in type I collagen turn- 
over in vivo, the murine genomic clone containing substi- 
tutions of Pro for Gin774  (P2) and Ala777 (P2') and Met for 
Ile776 (P1') (Mutant IV, see reference 58, Fig. 1), was mi- 
croinjected into  the  pronuclei  of FVB  mouse  embryos. 
Only a few transgenic animals were recovered: one of 13 
live embryos dissected at day 13 and one of 18 animals an- 
alyzed at weaning carried the transgene. The latter animal, 
a  male, was bred with FVB females to derive transgenic 
offspring. 
As shown in Table I, none of the 11 offspring that sur- 
vived to  weaning carried  the  transgene,  suggesting  that 
expression of the mutation might result in embryonic le- 
thality. Embryos at  different developmental stages were 
therefore isolated  and  genotyped by  Southern  analysis. 
Transgenic embryos developed normally up to day 14.5 (E 
14.5) of gestation. Between E  15 and E  16.5, however, only 
2 out of 13 total transgenics were alive and by day 19 there 
were no live transgenics (Table I). The most obvious phe- 
notypic abnormality of transgenic embryos was the failure 
to  close  the  abdominal  and  chest  cavities  (not  shown). 
These observations suggested that expression of the trans- 
gene in the offspring of the founder male interfered with 
normal embryogenesis. It was likely that a lower gene dos- 
age due to genetic mosaicism (54) might have allowed sur- 
vival of the founder male. Indeed, of 110 genotyped off- 
spring,  only  23  were  transgenic,  consistent  with  the 
founder being a germline mosaic. This was confirmed by 
comparing  the  number  of  the  transgene  copies  in  the 
founder  and  his  transgenic  offspring  by  quantitative 
Southern  analysis  (58).  While the founder had  approxi- 
Figure 1. Effects of human fibroblast  collagenase on collagens 
from wild-type and transgenic embryos. Proteins were extracted 
from E14 embryos from a litter.  Lanes 1, 2, 5, 6: Transgenics; 
lanes 3 and 4: a wild-type litter mate. Samples in lanes 7, 8 were 
collagens from mouse tail as control. Samples in lanes 1, 3, 5, and 
7 were incubated  with trypsin-activated  human  collagenase for 
18 h at 20°C (sufficient collagenase was used to digest 25 Izg col- 
lagen); samples in lanes 2, 4, 6, and 8 were incubated  in buffer 
without collagenase. 
Table L Genotype of Offspring Derived  from Transgenic 
Founder 
Total  Viable 
Age  animal  Transgenics  transgemcs 
E10.5-14.5  40  6  6 
E14.5-16.5  39  13 
E18-19  8  4 
Three weeks  11  0 
mately 20 copies of the transgene in his DNA, his offspring 
carried more than 70 copies (data not shown). 
To directly investigate whether increased mutant gene 
dosage  resulted in  augmented transgene expression, the 
amounts of mutant RNA in founder and offspring were 
compared. Quantitative S1 analysis (58) revealed that the 
level of transgene RNA in the founder was approximately 
25% of the endogenous Colla-1 RNA, whereas the level 
in its transgenic offspring was approximately 150%  (data 
not shown). To determine the composition of type I col- 
lagen chains produced in transgenic animals, collagen ex- 
tracted with pepsin in 0.5  M  acetic acid at 4°C was ana- 
lyzed by  SDS-PAGE.  As  shown  in  Fig.  1,  a  significant 
excess of etl(I) over et2(I) chains was noted in the transgen- 
ics (lanes 2 and 6) compared to control embryos (lane 4). 
These results indicate the presence of oil (I) trimers and are 
consistent with overexpression of the transgene. To assess 
whether the collagen was  resistant to cleavage, the pro- 
teins were incubated with human synovial collagenase. As 
seen in lanes 1 and 5, type I  collagen extracted from the 
transgenic embryos was highly resistant to cleavage com- 
pared to that from the control embryos (lane 3). These re- 
sults are consistent with those obtained previously where 
the same mutant construct was introduced into cultured 
Movl3 fibroblasts (58) and indicate that cleavage-resistant 
type I collagen was produced from the mutant transgene. 
Our results do not allow us, however, to conclude that the 
lethality of the transgenic embryos is due to the presence 
of the mutant otl(I) chains rather than the overexpression 
of the transgene. To resolve this issue, we used targeted 
mutagenesis  through homologous recombination in  em- 
bryonic stem  (ES) cells to introduce the same mutation 
into the endogenous Colla-1 gene. 
Mice Carrying Targeted Subtle Mutations at the 
Collagenase  Cleavage Site are Viable 
The  same  mutation  as  described  above  was  introduced 
into the endogenous Colla-1 gene of ES cells using the 
Hit-and-Run procedure (20, 60). The mutant allele of the 
Colla-1 gene was named Collal tm~ Jae according to the no- 
menclature rules (11). Chimeric mice, derived from C57/ 
BL6 or BALB/c blastocysts injected with targeted ES cell 
clones  were  derived  and  backcrossed  to  C57/BL6  or 
BALB/c  mice.  The  agouti  offspring were  genotyped  at 
weaning  by Southern  blot  analysis  to  identify germline 
transmission of the mutation. Heterozygous Collal  tin1 Jae 
mice were viable and, when intercrossed, produced wild- 
type, heterozygous and homozygous offspring at a normal 
Mendelian ratio based on Southern blot analysis (Fig. 2 
and Table 1I).  No gross abnormalities were observed in 
mutant mice through approximately three to six months 
of age. 
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from heterozygous Collal tmlJae breeding. (A) Restriction map of 
a 23.5-kb genomic DNA fragment covering Colla-1 gene. Muta- 
tion at the coding sequences for the collagenase cleavage site cre- 
ated a new Sph I site which was indicated with bold letters. (B) A 
representative Southern blot analysis of DNA samples from off- 
spring of heterozygous  mutant mice. DNAs were digested with 
Sph I  and  the Southern blots were  hybridized  with  the probe 
showed in A. Wild-type allele, 9 kb; mutant allele, 2.8 kb. 
Mutant Mice Develop Skin Alterations and Show 
Reproductive Impairment 
At approximately seven months of age, homozygous male 
Collal  tin1 J~ mice developed skin abnormalities consisting 
of thickening and roughening and associated with patchy 
hair loss and small ulcerations. Comparison of a section of 
skin from a ten month homozygous mutant male (Fig. 3 B) 
with that of skin from an age-matched control mouse (Fig. 
3 A) revealed that the dermis from the mutant mice was 
significantly thicker than that from control mice and was 
filled with dense collagen fibers. The collagen fibers were 
irregular in form and penetrated deeply into the hypoder- 
mis. The overall increased thickness of the skin in the ho- 
mozygous Col/al tml Jae mice extending from the epidermis 
to the muscular layer was accounted for by the increase in 
thickness of the dermis. Analysis of pepsin digests of mu- 
tant skin protein by SDS-PAGE and delayed reduction in- 
dicated  that  ~95%  of the  collagen was  type  I  collagen 
(data not shown). Homozygous female and heterozygous 
male and female mice developed similar but milder skin 
abnormalities compared to those of homozygous males at 
the same age (data not shown). 
Mutant females revealed a striking reproductive impair- 
ment. While wild-type females produce an average of four 
to five litters with a mean litter size of six pups during a 
seven months breeding period in our laboratory, both het- 
erozygous and  homozygous mutant  females produced  a 
significantly reduced number of litters which also tended 
to be small (Table III). It is well established that the col- 
Table I1. Genotype of Offspring Derived  from Heterozygous 
Parents 
Age  Wild-type  Heterozygous  Homozygous 
3 weeks  23  51  23 
(n =  97) 
lagen content of the uterus, which increases markedly dur- 
ing pregnancy, decreases strikingly within a few days after 
parturition  due  to  degradation  by collagenases  (24,  56). 
When the postpartum uteri of mutant females were com- 
pared to those of wild-type females, a  striking difference 
was seen: instead of a  tube-like structure with a  smooth 
outer surface, characteristic of normal postpartum  uteri, 
the uteri of mutant mice were filled with nodules.  Cross 
sections of these uteri showed that the nodules consisted 
of collagen fibers and these fibers occupied much of the 
endometrium and myometrium of the uterine wall (Fig. 4, 
A-D).  SDS-PAGE and analysis by delayed reduction of 
the pepsin digests of uterine protein showed that ~95 % of 
the collagen was type I collagen (data not shown). Colla- 
gen accumulation in the uteri of heterozygous Collal  tin1Jae 
mice  was  less  pronounced  compared  to  homozygous 
Collaltml Jae mice but was clearly different from wild-type 
females  (data  not  shown).  In  virgin  Collal tin1 Ja~  mice, 
small accumulations of collagen in the myometrium of the 
uterus were occasionally observed. 
The results described so far indicate that animals carry- 
ing the collagenase-resistant mutation develop normally to 
adulthood. Severe abnormalities, explainable by impaired 
collagen degradation, became manifest with increasing age 
or the challenge of intense collagen resorption. 
A Novel Collagenase  Cleavage Site at the 
NH2-terminus of al(I) Chain 
To confirm that  CoIlal tin1 Jae mice produce collagenase- 
resistant collagen, pepsin-resistant proteins were isolated 
from  tails  of  wild-type,  heterozygous  and  homozygous 
mice and digested with human synovial fibroblast collage- 
nase prior to SDS-PAGE. As shown in lanes 1  and 2  of 
Fig. 5 A, the al(I) and et2(I) collagen chains from wild- 
type mice were totally cleaved by collagenase into the ex- 
pected A ~1(I) and A ~2(1) (TC  A) and B ~1(I) and B ~2(I) (TC  B) 
fragments (the TC  B fragments migrated further than the 
TC  A and are not shown here in Fig. 5 A, or in Fig. 5, B and 
C). In contrast, collagens extracted from hemizygous mutant 
mice (Collal  TM Jae/Mov 13, for Mov 13 see reference 18), 
which express only the mutant but not the wild type etl(I) 
chain, were completely resistant to digestion (lanes 7 and 
8).  Collagens  extracted  from  the  tail  of  the  chimeric 
founder  mouse  and  from  a  heterozygous  Collal  tml Jae 
mouse  were  partially  resistant  to  collagenase  digestion 
(lanes 3--6). The extent of cleavage of the collagen from 
these heterozygous animals was 26% as calculated by den- 
sitometric scanning.  Quantitation  by cyanogen bromide 
cleavage (58) revealed that the distribution of mutant and 
wild-type a 1  (I) chains was approximately equal in the col- 
lagen extracted from the heterozygous animal  (data not 
shown).  This suggests  that  a  heterotrimer of type I  col- 
lagen containing a single mutated etl(I) chain is resistant to 
collagenase cleavage, consistent with a dominant negative 
effect of the mutation. 
The  observation  that  the  collagen  in  homozygous 
Collapml Jae mice was completely resistant to coUagenase 
degradation  raised  the  question  whether  other  mecha- 
nisms of degradation were responsible for the massive col- 
lagen turnover characteristic of embryonic development. 
The results described in Figs.  1 and 5 A  were based upon 
The Journal of Cell Biology, Volume 130, 1995  230 Figure 3. Histological analyses of the skin from ll-mo-old male wild-type and homozygous Collal  tmlJ"e  mice. (A) Wild-type skin. The 
epidermis  (E), dermis (D), hypodermis  (H), and hair follicle (F) are indicated. The collagen fibers are stained  blue with Masson's 
trichrome. (B) Homozygous mutant skin. The magnification is the same as A. Bar, 0.1 mm. 
digestion with human interstitial collagenase, which was 
the form of collagenase used in our initial study (58). To 
test  whether  the  mutant  collagen  was  also  resistant  to 
cleavage by rodent enzymes, collagens extracted from mu- 
Table IlL Number of Litter and Offspring Raised by Wild-type, 
tin1 Jae  Heterozygous,  and Homozygous Collal  Female 
Number 
Genotype  of litter  Litter size 
Wild-type  4.4  ___  1.1  5.9 -+  1.8 
(n =  5) 
Heterozygous  2.2  +_  0.9  4.4-e  1.6 
(n =  l0 females) 
Homozygous  1.4  _+  0.9*  4.7-~  1.5 
(n =  5 females) 
Breeding period: 7 months. 
Data expressed as mean _+ SEM. 
*Differs from wild-type, paired student t-test, P <  0.05. 
tant and control mice were incubated with rat collagenase 
obtained in highly purified form (40). As seen in Fig. 5 B, 
the rodent enzyme cleaves wild-type I collagen at a similar 
position as the human enzyme (lanes 2  and 3). Digestion 
of mutant collagen isolated from hemizygous mutant mice 
revealed,  however,  an  additional  cleavage  site  at  the 
amino end of collagen, which is not recognized by the hu- 
man enzyme. This conclusion was based on the observa- 
tion that the content of the 131,1 and 131,2  cross-linked dimer 
components from mutant mice was dramatically reduced 
after digestion with rat  collagenase  (lanes 3  and  6)  and 
that the expected A aa,1 and A ~1,2 cleavage products nor- 
mally seen after digestion of wild-type collagen with the 
human enzyme (lane 2) were absent. Instead, the intensity 
of bands corresponding to et 1(I) and a2(I) chains increased 
significantly, suggesting that the [31,1 and  ~1,2 components 
from mutant collagen were digested by rat collagenase to 
fragments that co-migrated with al(I) and a2(I) collagen 
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 Figure 5. Digestion of collagens from tails of wild-type mice and 
Collaltrat Jae mice. Collagenase digestion products were resolved 
by SDS-PAGE and stained with Coomassie blue. (A) Effects of 
human collagenase on collagens extracted by limited pepsin di- 
gestion from tails of three month-old mice. Samples in lanes 1 
and 2  were from a  wild-type mouse; samples in lanes 3  and 4 
were from a chimera; samples in Lanes 5, 6 were from a heterozy- 
gote; samples in Lanes 7, 8 were from a hemizygote (Collal  tin1Jae/ 
Movl3). Samples in lanes 2, 4, 6, and 8 had been incubated for 
18 h  at 20°C with previously activated human collagenase; sam- 
ples in lanes 1, 3, 5, and 7 had been incubated in buffer without 
collagenase. Note that collagen from the mutation IV hemizygote 
was resistant to digestion with collagenase whereas that from the 
wild-type was  completely digested under  the same conditions. 
(B) Effects of human and rat collagenase on collagens extracted in 0.5 M acetic acid without pepsin from tails of 3-mo-old mice. Samples 
in lanes 1-3 were from the wild-type mouse and samples in lanes 4--6 were from the mutation IV hemizygous mouse shown in A. Sam- 
ples in lanes l, 4 had been incubated in buffer without collagenase; samples in lanes 2, 5 had been incubated with human collagenase as 
in A; samples in lanes 3, 6 had been incubated with rat collagenase, 6.7 txg/ml. All samples had been incubated at 20°C for 18 h. Note that 
the human collagenase converted the 13 components of the wild-type collagen to A n and the a  chains to A ~ fragments, whereas the rat 
collagenase appeared to convert the 13 components as well as the ct chains to A ~ fragments. In contrast, whereas neither the human nor 
the rat collagenase cleaved the a  chains of the collagen containing mutation IV, the rat collagenase converted the 13 components of the 
collagen to et chains but the human collagenase did not appreciably diminish the concentration of the 13 components. (C) Effects of rat 
collagenase on collagens extracted in 0.5 M acetic acid without pepsin from skin of 3-mo-old mice. Samples in lanes 1, 2 were from a 
wild-type mouse; samples in lanes 3, 4 were from a homozygous Coll al tml Jae mouse. Samples in lanes 1, 3 had been incubated without 
collagenase; samples in lanes 2, 4 had been incubated with rat coUagenase, 6.7 ~g/ml. Samples had been incubated for 18 h  at 20°C. 
These results on the collagenase digestion of crosslinked collagen from the mouse homozygous for mutation IV are similar to those in B 
using collagen from the hemizygous mouse. 
chains.  Similar results  were  also  obtained  with  collagen 
isolated from  homozygous  Colctl  t~l J~e  mice  (Fig. 5  C). 
These results suggested that the rodent enzyme recognizes 
a  novel  cleavage  site  located  carboxy-terminal  to  the 
crosslinking site. 
To more accurately map the novel NH2-terminal colla- 
genase cleavage site, mutant type I  collagen was digested 
with  rat  collagenase  and  the  products  were  resolved  by 
SDS-PAGE and transferred to Immobilon-P membranes. 
The  appropriate  bands  were  excised  for  amino  acid 
sequence  analysis  and  the  results  of  the  digested  and 
undigested  samples  were  compared.  The  NH2-terminal 
sequence  of the  undigested al(I) chain was TyrAspGlu- 
LysSer  whereas  that  of  the  digested  etl(I)  chain  was 
ValSerValProGlyVal.  Comparison  with  the  peptide  se- 
quence  encoded  by the  nucleotide sequence  of Exons  6 
through  10  of the mouse  Colla-1  gene  (Breindl, M.,  un- 
published data) places the NH2-terminal rodent enzyme- 
specific cleavage site between a Gly and Val, four residues 
preceding the  start  of the  major helix  and  five  residues 
C-terminal to the putative cross-linking Lys (Fig. 6).  We 
conclude that the rat fibroblast collagenase recognizes two 
different sites in type I  collagen: (a) a  cleavage site in the 
collagen helical domain between residues 775  and 776  of 
the al(I) chain which is also recognized by all other colla- 
genases so far tested; (b)  a  second cleavage site COOH- 
terminal to the lysine-derived cross-link in the N-telopep- 
tide of the etl(I) chain. 
Discussion 
Embryonic Lethality of Transgenics Carrying a 
Collagenase-resistant Type I Collagen Gene 
It  has  been  well  established that  vertebrate  collagenase 
initiates degradation of native  collagen by cleavage at  a 
highly conserved sequence motif present in types I, II, and 
III collagens in  species as diverse as man  and Xenopus. 
Consistent with the conclusion that collagenase recognizes 
a  single  site  in  native  collagen,  point  mutations  of  the 
mouse  oH(I)  collagen  chain  such  as  mutation  IV  which 
would be predicted to affect cleavage and stabilize the tri- 
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Predicted from cDNA 
residue number 
end minor  N-peptidase  begm major 
hehx  cleavage  crosshnk  hehx 
GPPGLGGNFASOHSYG YDEKSAGVSVPGPHGPSG 
-1l  -4  +l 
Acid-soluble collagen 
No collagenase 
After rat collagenase 
YDEKSAGVSVPGPHGPSG 
VSVPGPP1GPSG 
novel 
rodent collagenase 
cleavage 
Figure  6. A novel cleavage site near the NH2 terminus of the (x 1(0 
chain. A partial  NH2-terminal  sequence of pro al(I) chain pre- 
dicted from the cDNA sequence and the NHz-terminal sequence 
of a 1  (I) chain with or without rat collagenase digestion were pre- 
sented. The amino acid residues are numbered as such; the gly- 
cine (G) at the beginning of the major helix is +1. Several other 
sites in this region are indicated with arrows. 
pie helix around the cleavage site render the protein resis- 
tant to degradation (58). Transgenic mice carrying muta- 
tion IV in multiple copies indeed produced type I collagen 
highly resistant to cleavage by coUagenase, indicating that 
the mutation had the predicted effect in vivo. With the ex- 
ception of the founder, animals carrying the transgene in- 
variably died. Previous experiments had established that 
the transgene constructs carried all known regulatory ele- 
ments required for tissue specific expression (unpublished 
data), suggesting that ectopic expression of the transgene 
was not the cause of lethality. The S1 analysis as well as 
protein analysis indicated that  the  transgene was  highly 
expressed, resulting in the accumulation of cleavage-resis- 
tant  type  I  collagen.  The  ratio  of  al(I)/a2(I)  peptide 
chains of type I collagen from transgenic mice varied from 
3:1 to 15:1 compared to 2:1 in the collagen from wild-type 
mice, consistent with the accumulation of al(I) homotri- 
mers (Fig. 1). Overexpression of collagen and the deposi- 
tion  of type  I  homotrimers lacking oL2(I) chains,  rather 
than expression of a  mutant collagen, may, therefore, be 
the primary explanation for the embryonic lethal pheno- 
type of the transgenics. This conclusion was confirmed by 
the lack of a lethal phenotype in mutant mice carrying the 
same mutation in the endogenous gene, as discussed be- 
low. We have observed occasionally that transgenic em- 
bryos  overexpressing  type  I  collagen  from  a  wild-type 
Colla-1 transgene died prenatally with a phenotype simi- 
lar to that observed with the mutant transgene described 
here (unpublished data). These observations support the 
notion that embryonic lethality may be caused by overex- 
pression of the transgene rather than by the mutation in- 
troduced. 
Attempts have been made to analyze the function of a 
particular gene  in  development by expressing a  mutant 
form of the protein in transgenic mice (dominant negative 
mutations: reference 22). Our results emphasize that cau- 
tion must be used in interpreting the data in transgenics 
carrying mutant transgenes since the phenotypes may not 
always be due to the expression of the mutant form of the 
protein but may also be due to overexpression or ectopic 
expression of the transgene. This caveat is particularly rel- 
evant when the stoichiometry of a multimeric protein such 
as collagen is altered by overexpression of one component 
of the multimer (23, 38, 41, 47, 49). 
Mice Producing Mutant Collagen From Collal  on1Jae 
Develop Normally to Adulthood 
In contrast to the transgenic mice discussed above, mice 
generated by gene targeting technology carrying the same 
mutation  in  their  endogenous  Colla-1  gene  developed 
normally to young adulthood and only later displayed al- 
terations  compatible  with  impaired  collagen  turnover. 
Type I  collagen isolated  from homozygous Collal tml Jae 
mice was completely resistant to cleavage by human inter- 
stitial synovial collagenase, confirming that the mutation 
had the predicted effect in vivo. Only 26% of collagen ex- 
tracted from heterozygous mutants was cleaved by the hu- 
man collagenase, suggesting that the mutation acted in a 
dominant negative manner. 
Our  observations  that  homozygous Collal  tin1 Jae  mice 
developed  normally  to  adulthood  posed  an  interesting 
problem: how could type I  collagen turnover be accom- 
plished  during embryogenesis in  the  absence  of a  func- 
tional collagenase cleavage site? The identification of the 
second site  at  the  N-telopeptide domain of the  protein, 
that is recognized by rodent fibroblast collagenase but not 
by the human enzyme, suggests the possibility that cleav- 
age at this previously unrecognized site could be sufficient 
to achieve collagen degradation during embryonic devel- 
opment. Cleavage at this site alone, however, seems not to 
be adequate to assure full equilibrium between collagen 
synthesis and degradation during later life. Our results are 
consistent with  the  concept that  enzymes with different 
specificity utilizing two distinct cleavage sites are involved 
in collagen degradation. The two sites may be of different 
significance  for type  I  collagen  degradation  in  prenatal 
and postnatal life. 
Tissue Remodeling in the Adult Depends on a 
Functional Collagenase  Cleavage Site between Amino 
Acid Residues 775 and 776 
As mutant mice aged, they developed a number of alter- 
ations which reflected their inability to degrade type I col- 
lagen during tissue remodeling. In the skin, the alterations 
consisted of thickening of the dermis, hair loss, and patchy 
ulcerations.  Histochemical  analysis  revealed  substantial 
accumulation of collagen in the dermis, indicating the im- 
portance  of collagen  turnover  in  the  skin  of the  adult 
mouse. It had been shown previously that cultured human 
skin produces large amounts of collagenase, but the signif- 
icance of this observation for the in vivo situation had not 
been established (4). The accumulation of collagen in the 
dermis from mutant mice suggests,  however, that type I 
collagen is actively turned over even in adult skin. Clearly, 
the  degradation of type I  collagen in  the  adult  depends 
critically on the presence of a functional collagenase cleav- 
age site between Gly775 and Ile776. In contrast, cleavage at 
the newly defined N-telopeptide site by rat collagenase or 
another, as yet unidentified proteinase, may be sufficient 
for collagen degradation during embryonic development 
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terations in the skin of mutant mice resemble those seen in 
the  skin of patients with scleroderma (thickening of the 
dermis and accumulation of irregular collagen fibers; ref- 
erences 32, 39). This raises the possibility that mutations at 
the collagenase cleavage site of type I collagen contribute 
to the dermal fibrosis in some patients with scleroderma. 
The second major defect caused by the mutant collagen 
became  evident  in  the  impaired  reproductive ability  of 
mutant females.  In mammals,  the  uterine collagen mass 
changes  considerably during  pregnancy and  postpartum 
involution (16, 17, 33, 55). In mice, the total uterine col- 
lagen mass increases up to 20-fold during pregnancy, and 
after parturition the  uterus rapidly recovers to prepreg- 
nant  size.  This  postpartum  involution  is  accomplished 
within the first two days after giving birth  and involves 
transcriptional activation of the collagenase gene and in- 
creased release of collagenase extracellularly followed by 
the massive degradation of most of the collagen deposited 
in the uterus within a few days (44, 45). In mutant females, 
degradation of collagen was severely disturbed, leading to 
the  accumulation  of nodules  in  the  uterine  wall.  These 
nodules consisted of large collagen aggregations, reflecting 
the impaired collagen degradation during the postpartum 
period. The maintenance of a high collagen content in the 
postpartum  uterus is  presumably responsible for the re- 
duced number of litters and decreased litter size of mutant 
females. Our results suggest that the massive degradation 
of collagen at the time of parturition is critically depen- 
dent on the presence of a functional cleavage site between 
Gly775 and Ile776. Our observations that there is a diffuse as 
well as nodular pattern to the collagen deposition in the 
mutant  postpartum  uterus  suggests  that  the  intensity of 
the normal resorptive process initiated at the time of par- 
turition is not uniform throughout the uterus. 
A  third manifestation of the mutation was seen in bone 
remodeling. Preliminary observations suggest that, while 
overall  bone  development  was  normal  in  Collal tin1 J~ 
mice, deformities of the tibia and increased deposition of 
trabecular and cortical bone in femurs and tibias were fre- 
quent after the age of 6 too, suggesting that bone remodel- 
ing may also be affected (unpublished observations). 
Type I Collagen Degradation Is Initiated at Two 
Distinct Cleavage Sites 
The discovery of a novel cleavage site recognized by the 
rat fibroblast collagenase but not the known human, bo- 
vine, porcine or rabbit enzymes provides new insights into 
the mechanisms of collagen turnover in development and 
disease (summarized in Fig. 7). Previously it was thought 
that the major mechanism of degradation of native col- 
lagen involves cleavage between Gly775  and Ile or Leu776, a 
highly  conserved sequence  recognized by all  interstitial 
collagenases.  We  have  shown  here  that  rat  collagenase 
cleaves, in addition, the type I  heterotfimer in the N-telo- 
peptide region of the a 1(I) chain between a Gly-Val bond 
four residues before the sequence Gly-Pro-Met, the first 
triplet  of the  major collagen helix.  Consistent  with  this 
specificity  is  the  observation  that  several  collagenases 
cleave a variety of susceptible peptide bonds in noncollag- 
enous proteins, including  a  Gly-Val bond in  the human 
al(1) 
al(l)  °-°  ~..  "  ~.-  ""  ..  "~  . 
a2(D 
SOME  ~  ALL  COLLAGENASES  ~ COLLAGENASES 
775  776 
GI¥  Pro  Gln  Gllv  Zla  Ala  GI¥  Gin  lta~g 
Gly  Pro  Gin  Gly  Leu  Leu  Gly  Ala  Pro 
Lye  Sez  Arg  G1y  Val  SIr  Val  Pro  G1F  Pro  Met 
-5  -4  1 
Figure 7. Proposed scheme for collagenase cleavage of type I col- 
lagen. Type I collagen is a helical trimeric molecule consisting of 
two al(I) chains and one a2(I) chain. The position of interchain 
crosslinks that involve modified Lys side chains, at residue -5, in 
the N-telopeptide region between the etl(I) chains or between 
one cd(I) chain and the ~2(I) chain is indicated. These modified 
Lys residues would also be involved in intermolecular  crosslinks 
in collagen fibrils and fibers. Degradation of type I collagen re- 
quires the cleavage by collagenases at defined sites in the mole- 
cule. All collagenases so far described recognize a cleavage site in 
the helical portion of the molecule,  as shown, between  amino 
acid residues 775 and 776. Some collagenases, such as the rodent 
fibroblast collagenases, recognize an additional site in the N-telo- 
peptide region and would cleave between the Gly at residue  -5 
and Val at -4 as demonstrated in this report (Fig. 6). 
pregnancy  zone  protein  (8,  46).  Proteinases,  including 
metalloproteinases other than the collagenases so far de- 
scribed (see below), might also function in the degradation 
of collagen by cleaving the proteins in the nonhelical do- 
mains. For example, stromelysin has been shown to cleave 
another interstitial collagen, type II collagen, at sites in the 
N-telopeptide region (61). 
The novel cleavage site recognized by the rodent en- 
zyme would have been difficult to detect using the wild- 
type type I collagen as a substrate. In our experiments, the 
use of animal tissues which contain crosslinked collagen as 
a source of mutant collagen facilitated the identification of 
the novel cleavage site. Digestion of wild-type but not the 
mutant type I collagen by the human enzyme cleaved the 
[31,1 and  [31.z cross-linked  dimers  to  the  A  131'1 and  A ~1,2 
products. In contrast, the rodent enzyme, cleaving COOH- 
terminal to the cross-link, further digested the A ~a,1 and 
A ~1,2 dimers  to A =1  and  A ~2 and  cleaved [31,1 and  [31,2 
from mutant mice to fragments comigrating with al (I) and 
a2(I) chains (Fig. 5). In previous studies with rat collage- 
nase,  the  NHz-terminal  cleavage  site  was  not  detected 
since the substrate used contains little crosslinked collagen 
and the digestion did not reach completion (42, 51). 
While our studies were in progress, the mouse fibroblast 
eollagenase  gene  was  cloned  and  sequenced  (21).  Se- 
quence comparison of the mouse and rat collagenases re- 
vealed 97% identity at the amino acid level whereas both 
differ significantly from the human neutrophil and fibro- 
blast collagenases as well as the porcine, rabbit and bovine 
fibroblast enzymes (52-53% amino acid sequence identity, 
references 14, 19, 53). Recently, we have found that mouse 
collagenase, similar to the rat enzyme, cleaves type I col- 
lagen at the NHz-terminal site (Krane, S.,  M. Byrne, Y. 
Eeckhout, P. Henriet, V. Lemaitre, X. Liu, H. Wu, R. Jae- 
nisch, manuscript in preparation) suggesting that the ro- 
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ent specificities than those of the previously characterized 
mammalian enzymes. It has just been reported that during 
murine embryonic development,  expression of this colla- 
genase  is  not  detected  by  in  situ  hybridization  until 
E15(31). At that time expression is limited to cells in the 
developing  skeleton  such  as  hypertrophic  chondrocytes, 
osteoblasts and endothelial cells. In view of these findings 
and those described in this paper, the action of other pro- 
teinases must also be necessary for the soft tissue remodel- 
ing during embryonic  growth.  A  new enzyme  with 86% 
amino  acid  sequence  identity to  the rodent collagenases 
has recently been cloned from a human breast carcinoma 
library (13). This enzyme likely represents a human homo- 
logue of the rodent enzymes  and would therefore  be ex- 
pected  to  cleave  type  I  collagen  at  the  NHz-terminal  as 
well as the helical sites.  Another enzyme, the human 72- 
kD  gelatinase  (type IV collagenase),  has been shown re- 
cently to cleave helical collagens at the same  Gly775/Leu776 
locus  as  the  collagenases  if  the  preparations  are  free  of 
TIMP (1). It is not yet known whether this enzyme could 
cleave  in  the  N-telopeptide  region.  Therefore,  the  en- 
zymes that are responsible for the collagen resorption dur- 
ing embryonic remodeling remain to be determined.  The 
normal development of the mutant mice to adulthood sug- 
gests that cleavage at the NH2-terminal site is one possibil- 
ity to account for normal type I collagen degradation dur- 
ing embryogenesis  and early adulthood. The pathological 
changes  seen  in  older  animals,  however,  suggest  that 
cleavage  between  Gly775 and  Ile776 is  essential  for  rapid 
collagen turnover in the adult. 
The phenotype of the mice has some resemblance to hu- 
man scleroderma.  It will therefore be of major interest to 
investigate  whether  similar  mutations  around the helical 
collagenase cleavage site occur in humans. It is also impor- 
tant to establish the role of the novel N-telopeptide cleav- 
age  during embryogenesis  and postnatal life.  Mice carry- 
ing mutations at this site should provide an excellent tool 
for further investigating type I collagen turnover in physi- 
ological and pathological remodeling of the extracellular 
matrix during embryogenesis and adulthood. 
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